Ocular Surface Disease

Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation that discussed the pharmaceutical treatment of anterior segment inflammatory conditions.

Jessilin Quint, OD, MBA, MS, FAAO, shares the latest and greatest in the world of dry eye, from new technology to how clinicians can start in on dry eye therapy today.

The evolution opens doors for the treatment of neurotrophic keratitis and beyond.

Mydcombi is the first FDA-approved, fixed-combination of tropicamide and phenylephrine for the reversal of mydriasis.

Selina McGee, OD, FAAO, Dipl ABO, shares highlights from her featured symposium, "Thyroid eye disease: The masquerading eye disorder," which she co-presented during the 2023 Controversies in Modern Eye Care meeting.

Several eye conditions may benefit from membrane application.

Help patients establish a daily eye care routine like the one they have for oral health.

The authors conducted a prospective non-interventional study in which a self-questionnaire was used to evaluate the ocular symptoms and medical background of patients with KC and OSD who engage in chronic eye rubbing.

The ones you should seek out—and avoid.

A look back on what's happened in optometry during the week of March 3-March 9.

Treatment should be adjusted based on disease severity.

A look back on what's happened in optometry during the week of February 25-March 2.

Supplementing vision care with nutrition may protect ocular tissues.

A look back on what's happened in optometry during the week of February 18-February 23.

The Biosciences group of the Centre for Ocular Research and Education (CORE) determined protein deposits on rigid gas permeable contact lens via radioactive counts by using a radiolabeled lysozyme in an artificial tear solution.